← Leaderboards
Ramasamy Paulmurugan
Stanford University
$4,501,543
Attributed
$7,308,482
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $863K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,308,482 · 7
By mechanism
R01$6,045,110 · 3
R21$824,706 · 2
R43$264,958 · 1
S10$173,708 · 1
Top collaborators
- Jeremy Dahl8 shared
- Tarik F Massoud2 shared
- Raghu S Pandurangi2 shared
- Juergen Karl Willmann1 shared
Most similar at Stanford University
Same institution · by research overlap
- Jianghong Rao$21,022,312
- Armando Ricardo Hernandez$165,328
- King C. Li$4,794,334
- Jeremy Dahl$13,959,707
- Tarik F Massoud$335,660
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsIn VivoMonitorImageBaseTumorNeoplasm MetastasisPharmaceutical PreparationsTumor GrowthProteinsMolecular ImagingGene ExpressionMicrobubblesLiverUltrasonographyAnimalsDrug Delivery SystemsIncidenceUnited StatesGenesClinical TranslationMediatingBlood CirculationAntineoplastic Agents
Grant awards (19)
B7-H3 Targeted Ultrasound Molecular Imaging System for Early Breast Cancer and Metastatic Detection$579,412
R01 · FY2025 · EB
B7-H3 Targeted Ultrasound Molecular Imaging System for Early Breast Cancer and Metastatic Detection$555,002
R01 · FY2024 · EB
B7-H3 Targeted Ultrasound Molecular Imaging System for Early Breast Cancer and Metastatic Detection$561,662
R01 · FY2023 · EB
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery$576,664
R01 · FY2021 · CA · contact PI
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery$622,615
R01 · FY2020 · CA · contact PI
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery$615,180
R01 · FY2019 · CA · contact PI
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery$640,842
R01 · FY2018 · CA · contact PI
Celigo S Imaging Cytometer (200-BFFL-S)$173,708
S10 · FY2018 · OD · contact PI
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery$617,907
R01 · FY2017 · CA · contact PI
3D Passive Cavitation Imaging-Guided Therapeutic Delivery of MicroRNA into Cancer$245,069
R21 · FY2017 · EB · contact PI
3D Passive Cavitation Imaging-Guided Therapeutic Delivery of MicroRNA into Cancer$195,444
R21 · FY2016 · EB
AAAPT Technology for Improving Chemotherapy$40,000
R43 · FY2016 · CA
Molecular Sensors for Imaging Histone Methylations in Living Animals$326,420
R01 · FY2015 · CA · contact PI
Druggable p53 misfolding in cancer: A novel in vivo molecular imaging biosensor$209,554
R21 · FY2015 · CA
Molecular Sensors for Imaging Histone Methylations in Living Animals$316,592
R01 · FY2014 · CA · contact PI
Dual Targeted Human Beta Defensin for Improving Chemotherapy$224,958
R43 · FY2014 · CA
Druggable p53 misfolding in cancer: A novel in vivo molecular imaging biosensor$174,639
R21 · FY2014 · CA
Molecular Sensors for Imaging Histone Methylations in Living Animals$306,633
R01 · FY2013 · CA · contact PI
Molecular Sensors for Imaging Histone Methylations in Living Animals$326,181
R01 · FY2012 · CA · contact PI